It also unfolds its T-cell suppressing function through at least three other ligands such as FGL-1, a liver secreted protein which is also highly upregulated in several cancers, Gal-3, which derives from tumor cells and activated T-lymphocytes and LSECtin, mainly produced by tumor cells [5, 24]. This evidence concerns the gene CLEC4G and neoplasm.